Keros Therapeutics, Inc. Convertible Preferred Dividends, Net of Tax
Keros Therapeutics, Inc. (KROS) reported Convertible Preferred Dividends, Net of Tax of $0 for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-10.
Discontinued › Notes
us-gaap:ConvertiblePreferredDividendsNetOfTax · last filed 2020-11-10
- Keros Therapeutics, Inc. convertible preferred dividends, net of tax for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Keros Therapeutics, Inc. convertible preferred dividends, net of tax for the quarter ending 2020-06-30 was $206.00K, a 54.22% decline year-over-year.
- Keros Therapeutics, Inc. convertible preferred dividends, net of tax for the quarter ending 2020-03-31 was $806.00K, a 79.11% increase year-over-year.
- Keros Therapeutics, Inc. convertible preferred dividends, net of tax for the quarter ending 2019-09-30 was $450.00K.
| Period end | Convertible Preferred Dividends, Net of Tax 3 month | Convertible Preferred Dividends, Net of Tax 6 month | Convertible Preferred Dividends, Net of Tax 9 month |
|---|---|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 | $206.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.01M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $206.00K 10-Q · filed 2020-08-13 | $1.01M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $806.00K 10-Q · filed 2020-05-22 | ||
| 2019-09-30 | $450.00K 10-Q · filed 2020-11-10 | $900.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.35M 10-Q · filed 2020-11-10 |
| 2019-06-30 | $450.00K 10-Q · filed 2020-08-13 | $900.00K 10-Q · filed 2020-08-13 | |
| 2019-03-31 | $450.00K 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |